🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

5 mL Serving Size
48 Servings
Fat/Fatty Acid Product Type
0% Evidence Coverage

Supplement Facts — Evidence Check

Calories
45 {Calories}
Total Fat
5 Gram(s) (8% DV)
Cholesterol
30 mg (10% DV)

Other Ingredients

natural Lemon flavor Mixed Tocopherols

Label Claims — Verification

All Other
All Other (99% of products) Structure/Function (86% of products) Nutrient (79% of products) Qualified Health (13% of products) Approved Health (2% of products)

Target Groups

Adult (18 - 50 Years) Gluten Free

Product Information

📋 Directions for Use

Recommended Use: As a dietary supplement, take 5 ml (approx. one teaspoon) per day with a meal, or as directed by your health care practitioner.

⚠️ Warnings & Precautions

Contains fish. Manufactured from anchovy, herring or sardines.

Warning: Consult your health care practitioner before use if you are taking blood thinning medication or are planning to have surgery.

🧪 Formulation Notes

Does not contain gluten.

OmegAvail(TM) Liquid is molecularly distilled and filtered to ensure purity and to maximize the removal of metals, pesticides, PCBs, and other contaminants.

Mixed tocopherols (antioxidant) are added to enhance stability of the product.

Additional Information

Notice: This is a natural product that may exhibit color, taste and density variations from lot to lot.

OAM8OZ-1

For Professional Use Only

Guaranteed GMP COMPLIANT Products

Manufactured in an NSF GMP Registered Facility

TruTG TRUE TRIGLYCERIDE BOUND EPA & DHA(TM)

REFRIGERATE AFTER OPENING. BEST IF USED WITHIN 90 DAYS AFTER OPENING.

Product Details

UPC / SKU 8 79452 00241 8
DSLD Entry Date 2013-06-25
Product Type Fat/Fatty Acid
Form Liquid
DSLD ID 22791
Data Updated 2026-04-11

Research Evidence

495 Research Sources
56 Avg Quality Score
222 Meta Analysis
104 Clinical Trial
72 Rct
69 Systematic Review
11 Guideline
5 Cochrane Review
5 Regulatory Source
3 Narrative Review
1 Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018
View all evidence for Omega 3 →

Compare Similar Products

View all Omega 3 products →